North America Next Generation Sequencing (NGS) Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	198 Pages	Data Bridge Market Research	April, 2024	DAABD18813155

Best Price Guarantee
Price	from $3,500
Length	198 Pages
Publisher	Data Bridge Market Research
Published Date	April, 2024
SKU	DAABD18813155

North America Next Generation Sequencing (NGS) Market

The North America next generation sequencing (NGS) market is expected to reach USD 15.79 billion by 2031 from USD 4.74 billion in 2023, growing at a CAGR of 16.9% in the forecast period of 2024 to 2031.

Market Segmentation
North America Next Generation Sequencing (NGS) Market, By Product & Service (Consumables, Services, and Instruments), Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Others), Application (Pharmaceuticals Microbiology, Drug & Biomarker Discovery, Diagnostics, Precision Medicine, Agricultural & Animal Research, Food Pathogen Screening, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Clinical Laboratories, Contract Research Organizations (CROS), and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031

Overview of North America Next Generation Sequencing (NGS) Market Dynamics
Drivers
• Increase in the adoption of genome-focused pharmacology
• Wide product portfolio offered by major players
• Use of next generation sequencing in drug development
• Increase trend towards personalized medication
Restraints
• High cost of installation and maintenance of equipment's in the laboratory
• Complexity during implementation of NGS in the clinical lab
Opportunities
• Strategic initiatives by the key market players
• Increasing advancement in NGS technology
• Increasing applications of NGS in clinical diagnostics
Challenges
• Lack of skilled professionals to perform NGS
• Data privacy and security

Market Players
The key market players operating in the North America next generation sequencing (NGS) market are listed below:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN
• Merck KGaA
• Charles River Laboratories
• Revvity
• Promega Corporation.
• Agilent Technologies, Inc.
• Takara Bio Inc.
• Eurofins Scientific
• Hamilton Company
• BGI
• Azenta US, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• PacBio.
• Macrogen, Inc.
• Gilson Incorporated
• New England Biolabs
• Oxford Nanopore Technologies plc.
• LGC Biosearch Technologies
• PCR Biosystems
• ACT Genomics
• Quantabio
• DNASTAR
• NimaGen.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Next Generation Sequencing (Ngs) Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 DBMR Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 Product Lifeline Curve; 2.9 DBMR Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porters Five Forces
5 Market Overview: 5.1 Drivers; 5.1.1 Increase In The Adoption Of Genome-focused Pharmacology; 5.1.2 Wide Product Portfolio Offered By Major Players; 5.1.3 Use Of Next Generation Sequencing In Drug Development; 5.1.4 Increase Trend Towards Personalized Medication; 5.2 Restraints; 5.2.1 High Cost Of Installation And Maintenance Of Equipment’s In The Laboratory; 5.2.2 Complexity During Implementation Of Ngs In The Clinical Lab; 5.3 Opportunities; 5.3.1 Strategic Initiatives By The Key Market Players; 5.3.2 Increasing Advancement In Ngs Technology; 5.3.3 Increasing Applications Of Ngs In Clinical Diagnostics; 5.4 Challenges; 5.4.1 Lack Of Skilled Professionals To Perform Ngs; 5.4.2 Data Privacy And Security
6 North America Next Generation Sequencing (Ngs) Market, By Product And Service: 6.1 Overview; 6.2 Consumables; 6.2.1 Library Preparation Consumables; 6.2.2 Sample Preparation Consumables; 6.3 Services; 6.3.1 Sequencing Services; 6.3.1.1 Rna Sequencing; 6.3.1.2 Dna Sequencing; 6.3.1.2.1 Whole Genome Sequencing; 6.3.1.2.2 Whole Exome Sequencing; 6.3.1.2.3 Targeted Sequencing; 6.3.1.2.4 Chip Sequencing; 6.3.1.2.5 De Novo Sequencing; 6.3.1.2.6 Others; 6.3.2 Data Management Services; 6.3.2.1 Ngs Storage, Management And Cloud Computing Solutions; 6.3.2.2 Ngs Data Analysis Software And Workbenches; 6.3.2.3 Ngs Data Analysis Services; 6.4 Instruments; 6.4.1 Benchtop; 6.4.2 Standalone; 6.4.2.1 Automated; 6.4.2.2 Semi-automated; 6.4.2.3 Manual; 6.4.2.3.1 Workstation/Platform; 6.4.2.3.2 System
7 North America Next Generation Sequencing (Ngs) Market, By Technology: 7.1 Overview; 7.2 Sequencing By Synthesis (Sbs); 7.2.1 Pyrosequencing; 7.2.2 Ion Semi Conductor Sequencing; 7.2.3 Nanopore Sequencing; 7.2.4 Single-molecule-real-time Sequencing (Smrt); 7.3 Sequencing By Ligation (Sbl); 7.4 Others
8 North America Next Generation Sequencing (Ngs) Market, By Application: 8.1 Overview; 8.2 Pharmaceuticals Microbiology; 8.2.1 Microbial Identification/Detection; 8.2.2 Targeted Sequencing; 8.2.3 Cell Line Characterization; 8.2.4 Antimicrobial Resistance And Predicting Antimicrobial Susceptibilities; 8.2.5 Strain Subtyping; 8.2.6 Others; 8.2.6.1 Sequencing By Synthesis (Sbs); 8.2.6.2 Sequencing By Ligation (Sbl); 8.2.6.3 Others; 8.3 Drug & Biomarker Discovery; 8.3.1 Sequencing By Synthesis (Sbs); 8.3.2 Sequencing By Ligation (Sbl); 8.3.3 Others; 8.4 Diagnostics; 8.4.1 Cancer Diagnostics; 8.4.2 Infectious Disease Diagnostics; 8.4.3 Reproductive Health Diagnostics; 8.4.4 Other Diagnostic Applications; 8.4.4.1 Sequencing By Synthesis (Sbs); 8.4.4.2 Sequencing By Ligation (Sbl); 8.4.5 Others; 8.5 Precision Medicine; 8.5.1 Sequencing By Synthesis (Sbs); 8.5.2 Sequencing By Ligation (Sbl); 8.5.3 Others; 8.6 Agricultural & Animal Research; 8.6.1 Sequencing By Synthesis (Sbs); 8.6.2 Sequencing By Ligation (Sbl); 8.6.3 Others; 8.7 Food Pathogen Screening; 8.8 Others
9 North America Next Generation Sequencing (Ngs) Market, By End User: 9.1 Overview; 9.2 Pharmaceutical & Biotechnology Companies; 9.3 Academic & Research Institutes; 9.4 Hospitals & Clinics; 9.5 Clinical Laboratories; 9.6 Contract Research Organizations (Cros); 9.7 Others
10 North America Next Generation Sequencing (Ngs) Market, By Distribution Channel: 10.1 Overview; 10.2 Direct Tender; 10.3 Retail Sales; 10.3.1 Offline; 10.3.2 Online; 10.4 Others
11 North America Next Generation Sequencing (Ngs) Market, By Region: 11.1 North America; 11.1.1 U.S.; 11.1.2 Canada; 11.1.3 Mexico
12 North America Next Generation Sequencing (Ngs) Market: Company Landscape: 12.1 Company Share Analysis: North America
13 Swot Analysis
14 Company Profiling: 14.1 Illumina, Inc.; 14.1.1 Company Snapshot; 14.1.2 Revenueanalysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Developments; 14.2 Thermo Fisher Scientific Inc.; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Developments; 14.3 Qiagen; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Developments; 14.4 Merck Kgaa; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Charles River Laboratories; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Developments; 14.6 Act Genomics; 14.6.1 Company Snapshot; 14.6.2 Product Portfolio; 14.6.3 Recent Developments; 14.7 Agilent Technologies, Inc.; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development; 14.8 Azenta Us, Inc.; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Development; 14.9 Beckman Coulter, Inc.; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Developments; 14.10 Bio-rad Laboratories, Inc.; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Developments; 14.11 Bgi (A Subsidiairy Of Bgi Group) (2024); 14.11.1 Company Snapshot; 14.11.2 Product Portfolio; 14.11.3 Recent Development; 14.12 Dnastar; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 Eurofins Scientific; 14.13.1 Company Snapshot; 14.13.2 Revenue Analysis; 14.13.3 Product Portfolio; 14.13.4 Recent Developments; 14.14 Gilson Incorporated; 14.14.1 Company Snapshot; 14.14.2 Product Portfolio; 14.14.3 Recent Development; 14.15 Hamilton Company; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 Lgc Biosearch Technologies; 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Developments; 14.17 Macrogen, Inc.; 14.17.1 Company Snapshot; 14.17.2 Revenue Analysis; 14.17.3 Product Portfolio; 14.17.4 Recent Development; 14.18 New England Biolabs; 14.18.1 Company Snapshot; 14.18.2 Product Portfolio; 14.18.3 Recent Development; 14.19 Nimagen; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Oxford Nanopore Technologies Plc.; 14.20.1 Company Snapshot; 14.20.2 Revenue Analysis; 14.20.3 Product Portfolio; 14.20.4 Recent Developments; 14.21 Pacbio.; 14.21.1 Company Snapshot; 14.21.2 Revenue Analysis; 14.21.3 Product Portfolio; 14.21.4 Recent Developments; 14.22 Pcr Biosystems; 14.22.1 Company Snapshot; 14.22.2 Product Portfolio; 14.22.3 Recent Developments; 14.23 Promega Corporation.; 14.23.1 Company Snapshot; 14.23.2 Product Portfolio; 14.23.3 Recent Developments; 14.24 Quantabio; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development; 14.25 Revvity; 14.25.1 Company Snapshot; 14.25.2 Revenue Analysis; 14.25.3 Product Portfolio; 14.25.4 Recent Development; 14.26 Takara Bio Inc.; 14.26.1 Company Snapshot; 14.26.2 Revenue Analysis; 14.26.3 Product Portfolio; 14.26.4 Recent Developments
15 Questionnaire
16 Related Reports: Table 1 Instrument Cost Per Run; Table 2 Platform /Company Cost Per Run; Table 3 North America Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 4 North America Consumables In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 5 North America Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 6 North America Services In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 7 North America Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 8 North America Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 9 North America Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 10 North America Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 11 North America Instruments In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 12 North America Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 13 North America Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 14 North America Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 15 North America Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 16 North America Consumables In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 17 North America Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 18 North America Sequencing By Ligation (Sbl) In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 19 North America Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 20 North America Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 21 North America Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 22 North America Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 23 North America Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 24 North America Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 25 North America Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 26 North America Diagnostics In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 27 North America Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 28 North America Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 29 North America Precision Medicine In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 30 North America Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 31 North America Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 32 North America Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 33 North America Food Pathogen Screening In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 34 North America Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 35 North America Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 36 North America Pharmaceutical & Biotechnology Companies In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 37 North America Academic & Research Institutes In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 38 North America Hospitals & Clinics In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 39 North America Clinical Laboratories In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 40 North America Contract Research Organizations (Cros) In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 41 North America Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 42 North America Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 43 North America Direct Tender In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 44 North America Retail Sales In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 45 North America Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 46 North America Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 47 North America Next Generation Sequencing (Ngs) Market, By Country, 2022-2031 (Usd Million); Table 48 North America Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 49 North America Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 50 North America Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 51 North America Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 52 North America Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 53 North America Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 54 North America Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 55 North America Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 56 North America Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 57 North America Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 58 North America Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 59 North America Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 60 North America Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 61 North America Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 62 North America Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 63 North America Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 64 North America Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 65 North America Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 66 North America Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 67 North America Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 68 North America Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 69 North America Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 70 U.S. Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 71 U.S. Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 72 U.S. Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 73 U.S. Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 74 U.S. Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 75 U.S. Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 76 U.S. Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 77 U.S. Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 78 U.S. Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 79 U.S. Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 80 U.S. Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 81 U.S. Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 82 U.S. Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 83 U.S. Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 84 U.S. Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 85 U.S. Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 86 U.S. Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 87 U.S. Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 88 U.S. Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 89 U.S. Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 90 U.S. Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 91 U.S. Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 92 Canada Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 93 Canada Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 94 Canada Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 95 Canada Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 96 Canada Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 97 Canada Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 98 Canada Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 99 Canada Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 100 Canada Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 101 Canada Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 102 Canada Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 103 Canada Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 104 Canada Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 105 Canada Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 106 Canada Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 107 Canada Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 108 Canada Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 109 Canada Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 110 Canada Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 111 Canada Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 112 Canada Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 113 Canada Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 114 Mexico Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 115 Mexico Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 116 Mexico Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 117 Mexico Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 118 Mexico Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 119 Mexico Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 120 Mexico Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 121 Mexico Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 122 Mexico Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 123 Mexico Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 124 Mexico Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 125 Mexico Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 126 Mexico Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 127 Mexico Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 128 Mexico Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 129 Mexico Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 130 Mexico Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 131 Mexico Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 132 Mexico Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 133 Mexico Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 134 Mexico Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 135 Mexico Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Figure 1 North America Next Generation Sequencing (Ngs) Market: Segmentation; Figure 2 North America Next Generation Sequencing (Ngs) Market: Data Triangulation; Figure 3 North America Next Generation Sequencing (Ngs) Market: Droc Analysis; Figure 4 North America Next Generation Sequencing (Ngs) Market: North America Vs Regional Market Analysis; Figure 5 North America Next Generation Sequencing (Ngs) Market: Company Research Analysis; Figure 6 North America Next Generation Sequencing (Ngs) Market: Interview Demographics; Figure 7 North America Next Generation Sequencing (Ngs) Market: Market Application Coverage Grid; Figure 8 North America Next Generation Sequencing (Ngs) Market: DBMR Market Position Grid; Figure 9 North America Next Generation Sequencing (Ngs) Market: Vendor Share Analysis; Figure 10 North America Next Generation Sequencing (Ngs) Market: Segmentation; Figure 11 Increasing Adoption Of Ngs-based Tests In Oncology, Prenatal Screening, And Infectious Disease Surveillance Is Driving The Growth Of The North America Next Generation Sequencing (Ngs) Market From 2024 To 2031; Figure 12 The Product And Service Segment Is Expected To Account For The Largest Share Of The North America Next Generation Sequencing (Ngs) Market In 2024 And 2031; Figure 13 Drivers, Restraints, Opportunities And Challenges Of North America Next Generation Sequencing (Ngs) Market; Figure 14 North America Next Generation Sequencing (Ngs) Market: By Product And Service 2023; Figure 15 North America Next Generation Sequencing (Ngs) Market: By Product And Services, 2024-2031 (Usd Million); Figure 16 North America Next Generation Sequencing (Ngs) Market: By Product And Service, Cagr (2024-2031); Figure 17 North America Next Generation Sequencing (Ngs) Market By Product And Service, Lifeline Curve; Figure 18 North America Next Generation Sequencing (Ngs) Market: By Technology 2023; Figure 19 North America Next Generation Sequencing (Ngs) Market: By Technolog, 2024-2031 (Usd Million); Figure 20 North America Next Generation Sequencing (Ngs) Market: By Technolog, Cagr (2024-2031); Figure 21 North America Next Generation Sequencing (Ngs) Market By Technolog, Lifeline Curve; Figure 22 North America Next Generation Sequencing (Ngs) Market : By Application, 2023; Figure 23 North America Next Generation Sequencing (Ngs) Market : By Application, 2024-2031 (Usd Million); Figure 24 North America Next Generation Sequencing (Ngs) Market : By Application, Cagr (2024-2031); Figure 25 North America Next Generation Sequencing (Ngs) Market : By Application, Lifeline Curve; Figure 26 North America Next Generation Sequencing (Ngs) Market : By End User, 2023; Figure 27 North America Next Generation Sequencing (Ngs) Market : By End User, 2024-2031 (Usd Million); Figure 28 North America Next Generation Sequencing (Ngs) Market : By End User, Cagr (2024-2031); Figure 29 North America Next Generation Sequencing (Ngs) Market : By End User, Lifeline Curve; Figure 30 North America Next Generation Sequencing (Ngs) Market : By Distribution Channel, 2023; Figure 31 North America Next Generation Sequencing (Ngs) Market : By Distribution Channel, 2024-2031 (Usd Million); Figure 32 North America Next Generation Sequencing (Ngs) Market : By Distribution Channel, Cagr (2024-2031); Figure 33 North America Next Generation Sequencing (Ngs) Market : By Distribution Channel, Lifeline Curve; Figure 34 North America Next Generation Sequencing (Ngs) Market: Snapshot (2023); Figure 35 North America Next Generation Sequencing (Ngs) Market: Company Share 2023 (%)